CYP gene family variants as potential protective factors in drug addiction in Han Chinese
CYP gene family variants as potential protective factors in drug addiction in Han Chinese
复制标题
CYP基因家族变异作为汉族吸毒成瘾的潜在保护因素
DOI:
10.1002/jgm.2887
复制
发表时间:
2016-06
影响因子:
3.5
通讯作者:
Wang Zhenyuan
中科院分区:
文献类型:
--
作者:
Zhang Hongxing;Yang Qi;Zheng Wenkai;Ouyang Yongri;Yang Min;Wang Fengjiao;Jin Tianbo;Zhang Ji;Wang Zhenyuan
Background.There is growing evidence that genetic factors also contribute to drug addiction. The human cytochrome P450 has shown special interest because of pharmacokinetic variation in different individuals and populations, which is largely determined by the relevant genes. The present study aimed to investigate the polymorphism of the CYP/addicts relationship...Methods.We genotyped 13 tag single‐nucleotide polymorphisms (tSNPs) from three genes, including 692 cases and 700 controls. Sequenom MassARRAY RS1000 (Sequenom, Inc., San Diego, CA, USA) was used for SNP genotyping. Statistical analysis of the association between tSNPs and drug addiction was performed using the chi‐squared test and SNP Stats software (http://bioinfo.iconcologia.net)...Results.The T/T genotype of rs2242480 in CYP3A4 was associated with decreased risk in the recessive model (p = 0.0002). Allele frequency at rs3743484 in CYP1A2 showed significant differences between addicts and controls (p = 0.046; odds ratio = 0.80; 95% confidence interval = 0.65–1.00). In genetic model analyses, the minor C allele of rs3743484 in CYP1A2 was associated with a reduced risk of drug addiction based on analysis using codominant and additive models (p = 0.027 dominant model; p =0.038 additive model)...Conclusions.Our findings show that at allelic and genotypic level polymorphisms in CYP3A4 and CYP1A2 are significantly associated with a reduced risk of drug addiction in X'ian Han Chinese individuals. However, this result needs to be confirmed in additional studies. Copyright © 2016 John Wiley & Sons, Ltd.
登录
查看更多内容
影响因子:
44.1
作者:
Shi, YY;He, L
通讯作者:
He, L
DOI:
--
发表时间:
1994-07
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
T. Shimada;H. Yamazaki;M. Mimura;Y. Inui;F. Guengerich
通讯作者:
T. Shimada;H. Yamazaki;M. Mimura;Y. Inui;F. Guengerich
影响因子:
3.1
作者:
C. Yun;H. Park;S. J. Kim;H. K. Kim
通讯作者:
C. Yun;H. Park;S. J. Kim;H. K. Kim
影响因子:
6.7
作者:
He, P;Court, MH;von Moltke, LL
通讯作者:
von Moltke, LL
DOI:
10.1097/00008571-199310000-00003
发表时间:
1993-10-01
期刊:
PHARMACOGENETICS
影响因子:
--
作者:
SCHWEIKL, H;TAYLOR, JA;GOLDSTEIN, JA
通讯作者:
GOLDSTEIN, JA